Does shear wave ultrasound independently predict axillary lymph node metastasis in women with invasive breast cancer?

Breast Cancer Research and Treatment

Volumn 143, Issue 1, 2014, Pages 153-157

  Evans, Andrew ^a   Rauchhaus, Petra ^a   Whelehan, Patsy ^a   Thomson, Kim ^a   Purdie, Colin A ^a   Jordan, Lee B ^a   Michie, Caroline O ^a   Thompson, Alastair ^a   Vinnicombe, Sarah ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Breast cancer; Elastography; Metastasis; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER SURGERY; CONTROLLED STUDY; ELASTOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; INVASIVE BREAST CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; ONCOLOGICAL PARAMETERS; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SHEAR WAVE ELASTOGRAPHY; TUMOR CLASSIFICATION; TUMOR STIFFNESS; TUMOR VOLUME; ULTRASOUND SCANNER; VASCULAR INVASION;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; RISK FACTORS;

EID: 84892786191     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2747-z     Document Type: Article

References (27)

1. Berg WA, Cosgrove DO, Dore CJ, Schaefer FKW, Svensson WE, Hooley RJ, Ohlinger R, Mendelson EB, Balu-Maestro C, Locatelli M, Tourasse C, Cavanaugh BC, Juhan V, Stavros AT, Tardivon A, Gay J, Henry JP, Cohen-Bacrie C (2012) Shear-wave elastography improves the specificity of breast US: the BE1 multinational study of 939 masses. Radiology 262(2):435-449
2. Chang JM, Moon WK, Cho N, Yi A, Koo HR, Han W, Noh DY, Moon HG, Kim SJ (2011) Clinical application of shear wave elastography (SWE) in the diagnosis of benign and malignant breast diseases. Breast Cancer Res Treat 129(1):89-97
3. Evans A, Whelehan P, Thomson K, Brauer K, Jordan L, Purdie C, McLean D, Baker L, Vinnicombe S, Thompson A (2012) Differentiating benign from malignant solid breast masses: value of shear wave elastography according to lesion stiffness combined with greyscale ultrasound according to BI-RADS classification. Br J Cancer 107(2):224-229
4. Regner D, Hesley G, Hangiandreou N, Morton M, Nordland M, Meixner D, Hall T, Farrell M, Mandrekar J, Harmsen W, Charboneau J (2006) Breast lesions: evaluation with US strain imaging - clinical experience of multiple observers. Radiology 238:425-437
5. Burnside ES, Hall TJ, Sommer AM, Hesley GK, Sisney GA, Svensson WE, Fine JP, Jiang J, Hangiandreou NJ (2007) Differentiating benign from malignant solid breast masses with US strain imaging. Radiology 245(2):401-410
6. Cosgrove DO, Berg WA, Dore CJ, Skyba DM, Henry JP, Gay J, Cohen-Bacrie C (2012) Shear wave elastography for breast masses is highly reproducible. Eur Radiol 22(5):1023-1032
7. Youk JH, Gweon HM, Son EJ, Kim JA, Jeong J (2013) Shear-wave elastography of invasive breast cancer: correlation between quantitative mean elasticity value and immunohistochemical profile. Breast Cancer Res Treat 138(1):119-126
8. Evans A, Whelehan P, Thomson K, McLean D, Brauer K, Purdie C, Baker L, Jordan L, Rauchhaus P, Thompson A (2012) Invasive breast cancer: relationship between shear-wave elastographic findings and histologic prognostic factors. Radiology 263(3):673-677
9. Fitzgibbons PL, Page DL, Weaver D, Thor AD, Craig Allred D, Clark GM, Ruby SG, O'Malley F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ (2000) Prognostic factors in breast cancer. Arch Pathol Lab Med 124(7):966-978
10. Vandergrift JL, Niland JC, Theriault RL, Edge SB, Wong YN, Loftus LS, Breslin TM, Hudis CA, Javid SH, Rugo HS, Silver SM, Lepisto EM, Weeks JC (2013) Time to adjuvant chemotherapy for breast cancer in national comprehensive cancer network institutions. J Natl Cancer Inst 105(2):104-112
11. Bevilacqua JLB, Kattan MW, Fey JV, Cody Iii HS, Borgen PI, Van Zee KJ (2007) Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol 25(24):3670-3679
12. Qiu PF, Liu JJ, Wang YS, Yang GR, Liu YB, Sun X, Wang CJ, Zhang ZP (2012) Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients. Jpn J Clin Oncol 42(11):1002-1007
13. Houssami N, Ciatto S, Turner RM, Cody HS, MacAskill P (2011) Preoperative ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer: meta-analysis of its accuracy and utility in staging the axilla. Ann Surg 254(2):243-251
14. National Research Ethics Service (2008) Approval for medical devices research: guidance for researchers, manufacturers, research ethics committees and NHS R&D offices (Version 2). National Patient Safety Agency, London
15. Guidelines working group of the national coordinating committee for breast pathology (2005) Pathology reporting of breast disease (NHSBSP publication 58). NHS Cancer Screening Programmes & The Royal College of Pathologists, London
16. Purdie CA, Jordan LB, McCullough JB, Edwards SL, Cunningham J, Walsh M, Grant A, Pratt N, Thompson AM (2010) HER2 assessment on core biopsy specimens using monoclonal antibody CB11 accurately determines HER2 status in breast carcinoma. Histopathology 56(6):702-707
17. Conklin MW, Eickhoff JC, Riching KM, Pehlke CA, Eliceiri KW, Provenzano PP, Friedl A, Keely PJ (2011) Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am J Pathol 178(3):1221-1232
18. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SFT, Csiszar K, Giaccia A, Weninger W, Yamauchi M, Gasser DL, Weaver VM (2009) Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139(5):891-906
19. Chen LC, Tu SH, Huang CS, Chen CS, Ho CT, Lin HW, Lee CH, Chang HW, Chang CH, Wu CH, Lee WS, Ho YS (2012) Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway. Breast Cancer Research Treat. doi: 10.1007/s10549-012-1986-8
20. Farmer P, Bonnefoi H, Anderle P, Cameron D, Wirapati P, Becette V, Andr S, Piccart M, Campone M, Brain E, MacGrogan G, Petit T, Jassem J, Bibeau F, Blot E, Bogaerts J, Aguet M, Bergh J, Iggo R, Delorenzi M (2009) A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nat Med 15(1):68-74
21. Witkiewicz AK, Dasgupta A, Sotgia F, Mercier I, Pestell RG, Sabel M, Kleer CG, Brody JR, Lisanti MP (2009) An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. Am J Pathol 174(6):2023-2034
22. Hatzis C, Pusztai L, Valero V, Booser DJ, Esserman L, Lluch A, Vidaurre T, Holmes F, Souchon E, Wang H, Martin M, Cotrina J, Gomez H, Hubbard R, ChacÃn JI, Ferrer-Lozano J, Dyer R, Buxton M, Gong Y, Wu Y, Ibrahim N, Andreopoulou E, Ueno NT, Hunt K, Yang W, Nazario A, DeMichele A, O'Shaughnessy J, Hortobagyi GN, Symmans WF (2011) A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA 305(18):1873-1881
23. Kandemir NO, Barut F, Bektas S, Ozdamar SO (2012) Can lymphatic vascular density be used in determining metastatic spreading potential of tumor in invasive ductal carcinomas? Pathol Oncol Res 18(2):253-262
24. Kwok TC, Rakha EA, Lee AHS, Grainge M, Green AR, Ellis IO, Powe DG (2010) Histological grading of breast cancer on needle core biopsy: the role of immunohistochemical assessment of proliferation. Histopathology 57(2):212-219
25. O'Shea AM, Rakha EA, Hodi Z, Ellis IO, Lee AHS (2011) Histological grade of invasive carcinoma of the breast assessed on needle core biopsy - modifications to mitotic count assessment to improve agreement with surgical specimens. Histopathology 59(3):543-548
26. Boughey J, Suman V, Mittendorf E, Ahrendt G, Wilke L, Taback B, Leitch A, Flippo-Morton T, Byrd D, Ollila D, Julian T, McLaughlin S, McCall L, Symmans W, Le-Petross H, Haffty B, Buchholz T (2012) The role of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4, N1-2) who receive neoadjuvant chemotherapy - results from the ACOSOG Z1071 trial. Cancer Res 72((24 Suppl.)):Abstract nr S2-1
27. Kuehn T, Bauerfeind I, Fehm T, Fleige B, Helms G, Lebeau A, Liedtke C, von Minckwitz G, Nekljudova V, Schrenk P, Staebler A, Untch M (2012) Sentinel lymph node biopsy before or after neoadjuvant chemotherapy - final results from the prospective German, multiinstitutional SENTINA-trial. Cancer Res 72((24 Suppl.)):Abstract nr S2-2